Literature DB >> 19035422

Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus.

Pantelis Panopalis1, Jinoos Yazdany, Joann Zell Gillis, Laura Julian, Laura Trupin, Aimee O Hersh, Lindsey A Criswell, Patricia Katz, Edward Yelin.   

Abstract

OBJECTIVE: To estimate health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus (SLE) in the US.
METHODS: Data were derived from the University of California, San Francisco Lupus Outcomes Study. Participants provided information on their health care resource use and employment. Cost estimates were derived for both direct health care costs and costs related to changes in work productivity. Direct health care costs included costs for hospitalizations, emergency department services, physician visits, outpatient surgical procedures, dialysis, and medications. Productivity costs were estimated by measuring changes in hours of work productivity since diagnosis of SLE; these estimates were also compared with normal US population data.
RESULTS: For the total population of participants, the mean annual direct cost was $12,643 (2004 US dollars). The mean annual productivity cost for subjects of employment age (>or=18 and <65 years) was $8,659. The mean annual total cost (direct and productivity) for subjects of employment age was $20,924. Regression results showed that greater disease activity, longer disease duration, and worse physical and mental health were significant predictors of higher direct costs; older age predicted lower direct costs. Older age, greater disease activity, and worse physical and mental health status were significant predictors of higher costs due to changes in work productivity.
CONCLUSION: Both direct health care costs and costs associated with changes in work productivity are substantial and both represent important contributors to the total costs associated with SLE.

Entities:  

Mesh:

Year:  2008        PMID: 19035422      PMCID: PMC2875149          DOI: 10.1002/art.24063

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  27 in total

1.  A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.

Authors:  E Yelin; A Herrndorf; L Trupin; D Sonneborn
Journal:  Arthritis Rheum       Date:  2001-05

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Eligibility, utilization, and costs in a California Medicaid lupus population.

Authors:  Michael B Nichol; Sheng Shi; Tara K Knight; Daniel J Wallace; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2004-12-15

4.  The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition.

Authors:  S Gupta; G A Hawker; A Laporte; R Croxford; P C Coyte
Journal:  Rheumatology (Oxford)       Date:  2005-08-09       Impact factor: 7.580

5.  The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs.

Authors:  Pantelis Panopalis; Michelle Petri; Susan Manzi; David A Isenberg; Caroline Gordon; Jean-Luc Senécal; John R Penrod; Lawrence Joseph; Yvan St Pierre; Christian Pineau; Paul R Fortin; Nurhan Sutcliffe; Jean-Richard Goulet; Denis Choquette; Tamara Grodzicky; John M Esdaile; Ann E Clarke
Journal:  Arthritis Rheum       Date:  2007-02-15

6.  Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.

Authors:  Kaleb Michaud; Jodi Messer; Hyon K Choi; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2003-10

7.  Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.

Authors:  Edward Yelin; Miriam G Cisternas; David J Pasta; Laura Trupin; Louise Murphy; Charles G Helmick
Journal:  Arthritis Rheum       Date:  2004-07

8.  Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.

Authors:  E W Karlson; L H Daltroy; C Rivest; R Ramsey-Goldman; E A Wright; A J Partridge; M H Liang; P R Fortin
Journal:  Lupus       Date:  2003       Impact factor: 2.911

9.  Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.

Authors:  Jinoos Yazdany; Edward H Yelin; Pantelis Panopalis; Laura Trupin; Laura Julian; Patricia P Katz
Journal:  Arthritis Rheum       Date:  2008-01-15

10.  Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.

Authors:  J Ruof; J L Hülsemann; T Mittendorf; S Handelmann; J M von der Schulenburg; H Zeidler; S Merkesdal
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

View more
  26 in total

1.  Fatigue in systemic lupus erythematosus.

Authors:  Grace E Ahn; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2012-04-01

2.  Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus.

Authors:  Laura J Julian; Chris Tonner; Ed Yelin; Jinoos Yazdany; Laura Trupin; Lindsey A Criswell; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

3.  Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China.

Authors:  Xia Xie; Dongmei Wu; Hong Chen
Journal:  Rheumatol Int       Date:  2016-08-31       Impact factor: 2.631

4.  Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation.

Authors:  Jinoos Yazdany; Ben J Marafino; Mitzi L Dean; Naomi S Bardach; Reena Duseja; Michael M Ward; R Adams Dudley
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

5.  Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus.

Authors:  Laura J Julian; Steven E Gregorich; Chris Tonner; Jinoos Yazdany; Laura Trupin; Lindsey A Criswell; Ed Yelin; Patricia P Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

Review 6.  Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions.

Authors:  Kathryn A Wierenga; Jack R Harkema; James J Pestka
Journal:  Toxicol Pathol       Date:  2019-11-14       Impact factor: 1.902

Review 7.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

Review 8.  The humanistic and economic burden of systemic lupus erythematosus : a systematic review.

Authors:  Rachel Meacock; Nicola Dale; Mark J Harrison
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

Review 9.  Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider.

Authors:  Giuseppe Turchetti; Jinoos Yazdany; Ilaria Palla; Edward Yelin; Marta Mosca
Journal:  Clin Exp Rheumatol       Date:  2012-10-16       Impact factor: 4.473

10.  Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.

Authors:  So-Yeon Park; Young Bin Joo; Jeeseon Shim; Yoon-Kyoung Sung; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2015-08-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.